StonvexLoading…
StonvexStonvexStonvexCore line items from ED's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.05B | $15.47B | $14.48B | $15.46B |
Operating Income | $2.94B | $2.67B | $3.20B | $2.62B |
Net Income | $2.02B | $1.82B | $2.52B | $1.66B |
EPS (Diluted) | $5.64 | $5.24 | $7.21 | $4.66 |
Total Assets | $74.60B | $70.56B | $66.33B | $69.06B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.63B | $1.32B | $1.19B | $1.28B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-530.00M |
Shares Outstanding | 361.12M | 346.60M | 345.42M | 354.96M |